Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.

about

Predicting death and lost to follow-up among adults initiating antiretroviral therapy in resource-limited settings: Derivation and external validation of a risk score in Haiti

P2860

Q58696535-AFD2AD73-74CC-45F4-9A35-DA09A2AED7E6

P2860

Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.

Item

http://www.wikidata.org/entity/Q36349654

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Clinical decision tools are ne ...... ion of antiretroviral therapy.

@ast

Clinical decision tools are ne ...... ion of antiretroviral therapy.

@en

type

Item

label

Clinical decision tools are ne ...... ion of antiretroviral therapy.

@ast

Clinical decision tools are ne ...... ion of antiretroviral therapy.

@en

prefLabel

Clinical decision tools are ne ...... ion of antiretroviral therapy.

@ast

Clinical decision tools are ne ...... ion of antiretroviral therapy.

@en

P1476

Clinical decision tools are ne ...... ion of antiretroviral therapy.

@en

P2093

Margaret L McNairy

http://www.w3.org/2001/XMLSchema#string

Miriam Rabkin

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective Validation of the San Francisco Syncope Rule to Predict Patients With Serious Outcomes

Self-transfer and mortality amongst adults lost to follow-up in ART programmes in low- and middle-income countries: systematic review and meta-analysis

Translating clinical research into clinical practice: impact of using prediction rules to make decisions

A prediction rule to identify low-risk patients with community-acquired pneumonia

Mortality and loss-to-follow-up during the pre-treatment period in an antiretroviral therapy programme under normal health service conditions in Uganda.

Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.

Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

The importance of clinic attendance in the first six months on antiretroviral treatment: a retrospective analysis at a large public sector HIV clinic in South Africa.

An internationally generalizable risk index for mortality after one year of antiretroviral therapy.

Predicting virologic failure in an HIV clinic.

P304

e1002278

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PMED.1002278

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wafaa El-Sadr

Elaine J Abrams

P577

2017-04-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28419097

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

5395167

http://www.w3.org/2001/XMLSchema#string

Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.

about

P2860

P2860

Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932